Improved efficacy in the neoadjuvant treatment of locally advanced breast cancer (LABC)

被引：0
|
作者：
Smolanka, I. I.
Lygyrda, O. F.
Galakhin, K. A. [1 ]
Kudrjavetz, Y. J. [2 ]
机构：
[1] Inst Oncol, Dept Pathohistol, Kiev, Ukraine
[2] Pathol & Radiobiol NAS Ukraine, ER Kavetsky Inst Expt Oncol, Dept Bank Canc Cell Cultures, Kiev, Ukraine
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [1] NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST-CANCER (LABC)
    SWAIN, S
    LIPPMAN, M
    BAGLEY, C
    SORACE, R
    WESLEY, M
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 55 - 55
  • [2] Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).
    Puerto, VL
    Cardenas, J
    Lara, F
    Goana, R
    Silva, A
    Barroso, N
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 299 - 299
  • [3] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [4] COMBINED TREATMENT FOR LOCALLY ADVANCED BREAST-CANCER (LABC)
    COLOZZA, M
    GORI, S
    BELSANTI, V
    MOSCONI, A
    ROSSETTI, R
    BASURTO, C
    ANASTASI, P
    LATINI, P
    MARANZANO, E
    CHECCAGLINI, F
    MERCATI, U
    TONATO, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 125 - 125
  • [5] Additional metabolic effects at the neoadjuvant chemotherapy (NCT) of locally advanced breast cancer (LABC).
    Abramova, Natalya A.
    Vladimirova, Liubov Yu
    Shikhliarova, Alla I.
    Storozhakova, Anna E.
    Kova, Valeriya S. Myag
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Does neoadjuvant chemotherapy (NAC) alter biological markers in locally advanced breast cancer (LABC)?
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 121 - 121
  • [7] Locally advanced breast cancer (LABC): Neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC).
    Wynendaele, W
    Paridaens, R
    Wildiers, J
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S208 - S208
  • [8] Gross and histologic features of locally advanced breast cancer (LABC) after neoadjuvant chemotherapy (NAC).
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 122 - 122
  • [9] Dose-dense taxotere (T) and adriamycin/cyclophosphamide (AC) as neoadjuvant treatment in locally advanced breast cancer (LABC).
    García-Mata, J
    Calvo, L
    García-Palomo, A
    Mel, JR
    Almanza, MC
    Ramos, M
    de Paz, LH
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S226 - S227
  • [10] ACTIVITY AND SAFETY OF A COMBINATION OF EPIRUBICIN, DOCETAXEL AND CISPLATIN AS NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED BREAST CANCER (LABC): A PRELIMINARY REPORT
    Avci, N.
    Kanat, O.
    Gokgoz, S.
    Tolunay, S.
    Topal, U.
    Cubukcu, E.
    Olmez, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 129 - 129
12345